Statins and associated risk of pneumonia: A systematic review and meta-analysis of observational studies

European Journal of Clinical Pharmacology

Volumn 68, Issue 5, 2012, Pages 747-755

  Kwok, Chun Shing ^a   Yeong, Jessica Ka Yan ^a   Turner, Richard M ^b   Cavallazzi, Rodrigo ^c   Singh, Sonal ^d   Loke, Yoon Kong ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c University of Louisville School of Medicine   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Meta analysis; Pneumonia; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG USE; EMBASE; EVIDENCE BASED MEDICINE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PNEUMONIA; RISK FACTORS;

EID: 84864289937     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1159-4     Document Type: Article

References (37)

1. Chalmers JD, Short PM, Mandal P, Akram AR, Hill AT (2010) Statins in community acquired pneumonia: evidence from experimental and clinical studies. Respir Med 104(8):1081-1091
2. Jain MK, Ridker PM (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4:977-987
3. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R (2005) Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267-1278
4. Fedson DS (2006) Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 43:199-205
5. Alegret M, Silvestre JS (2006) Pleiotropic effects of statins and related pharmacological experimental approaches. Methods: Find Exp Clin Pharmacol 28:627-656 (Pubitemid 46133012)
6. Blanco-Colio LM, Tunon J, Martin-Ventura JL, Egido J (2003) Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 63:12-23 (Pubitemid 35463903)
7. Novack V, Terblanche M, Almog Y (2006) Do statins have a role in preventing or treating sepsis? Crit Care 10:113
8. Schonbeck U, Libby P (2004) Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents? Circulation 109[21 suppl 1]:II18-II26
9. Almog Y (2003) Statins, inflammation, and sepsis: hypothesis. Chest 124:740-743 (Pubitemid 37000158)
10. Almog Y, Novack V, Eisinger M, Porath A, Novack L, Gilutz H (2007) The effect of statin therapy on infection related mortality in patients with atherosclerotic diseases. Crit Care Med 35:372-378 (Pubitemid 46148524)
11. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A (2004) Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110:880-885 (Pubitemid 39096018)
12. Liappis AP, Kan VL, Rochester CG, Simon GL (2001) The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33:1352-1357 (Pubitemid 32955186)
13. Schlienger RG, Fedson DS, Jick SS, Jick H, Meier CR (2007) Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 27(3):325-332 (Pubitemid 46327900)
14. van den Garde EMW, Hak E, Souvereins PC, Hoes AW, van den Bosch JMM, Leufkens HGM (2006) Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 61:957-961 (Pubitemid 44787165)
15. Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA (2009) Statin use and risk of community acquired pneumonia in older people: population based case-control study. Br Med J 338:b2137. doi:10.1136/bmj.b2137
16. Fleming DM, Verlander NQ, Elliot AJ, Zhao H, Gelb D, Jehring D, Nguyen-van-tam JS (2010) An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006. Epidemiol Infect 138:1281-1288
17. Kwong JC, Li P, Redelmeier DA (2009) Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. PLoS ONE 4(11):8087
18. Douglas I, Evans S, Smeeth L (2011) Effect of statin treatment on short term mortality after pneumonia episode: cohort study. Br Med J 342:d1642
19. Yende S, Milbrandt EB, Kellum JA, Kong L, Delude RL, Weissfeld LA, Angus DC (2011) Understanding the role of statins in pneumonia and sepsis. Crit Care Med 39(8):1871-1878
20. Singh S, Loke YK, Furberg CD (2011) Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis. Thorax 66(5):383-388
21. Loke YK, Price D, Herxheimer A (2008) Chapter 14: adverse effects. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, Chichester
22. Ioannidis JP, Trikalinos TA (2007) The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. Can Med Assoc J 176(8):1091-1096 (Pubitemid 46649731)
23. Davies HT, Crombie IK, Tavakoli M (1998) When can odds ratios mislead? Br Med J 316(7136):989-991 (Pubitemid 28135151)
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327 (7414):557-560 (Pubitemid 37088507)
25. Le Manach Y, Ibanez Esteves C, Bertrand M, Goarin JP, Fleron MH, Coriat P, Koskas F, Fiou B, Landais P (2011) Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology 114(1):98-104
26. Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE (2009) Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 18(4):269-275
27. Rodriguez de Antonio LA, Martinez-Sanchez P, Martinez-Martinez MM, Cazorla-Garcia R, Sanz-Gallego FB, Diez-Tejedor E (2011) Previous statins treatment and risk of post-stroke infections. Neurologia 26:150-156
28. Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S (2009) Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol 67(1):99-109
29. Ioannidis JP, Patsopoulos NA, Rothstein HR (2008) Reasons or excuses for avoiding meta-analysis in forest plots. Br Med J 336:1413-1415
30. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ (2006) Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. Br Med J 333(7576):999
31. Schisterman EF, Cole SR, Platt RW (2009) Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20(4):488-495
32. Fessler MB, Young SK, Jeyaseelan S, Lieber JG, Arndt PG, Nick JA, Worthern GS (2005) A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Med 171(6):606-615 (Pubitemid 40365416)
33. Whittle J, Fine MJ, Joyce DZ, Lave JR, Young WW, Hough LJ, Kapoor WN (1997) Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual 12(4):187-193 (Pubitemid 127447173)
34. Beri A, Surai N, Mahajan SB (2009) Non-atheroprotective effects of statins: a systematic review. Am J Cardiovasc Drugs 9(6):361-370
35. Hippisley-Cox J, Coupland C (2010) Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. Br Med J 340:c2197. doi:10.1136/bmj.c2197
36. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF (1997) Incidence of community-acquired pneumonia requiring hospitalization Results: of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 157(15):1709-1718 (Pubitemid 27327407)
37. Loke YK, Kwok CS, Niruban A, Myint PK (2010) Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 65 (10):884-890